State Ledger
Company profile

Aprea Therapeutics, Inc. CIK 1781983

Ticker
APRE (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Doylestown, PA 18902
Fiscal year end
2025 (FY)
Market Data
Close
$0.59
Change
+$0.01
Change %
1.66%
Volume
2,000

APRE · trading date Oct 12, 2026 · previous close $0.58 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$12.60M
Total assets
$15.93M
Total liabilities
—
Stockholders' equity
$12.44M
Cash & equivalents
$14.60M
Operating income
-$13.23M
Operating cash flow
-$12.89M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
78.1%
CapEx / revenue
—
Operating cash flow / net income
1.02×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$12.60M $15.93M — $12.44M
2024 — -$12.96M $23.98M — $19.31M
2023 — -$14.29M $22.65M — $16.95M
2022 — -$112.66M $30.16M $3.20M $25.64M
2021 — -$37.13M $56.82M $7.32M $49.51M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-28
Financials filed via
Form 10-K
filed 2026-03-16

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Doylestown, PA 18902
3805 OLD EASTON ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Pennsylvania — Public Companies